Cargando…
Bone marrow mesenchymal stromal cells for diabetes therapy: touch, fuse, and fix?
Bone marrow mesenchymal stromal cells (BM-MSCs) have anti-inflammatory and pro-survival properties. Naturally, they do not express human leukocyte antigen class II surface antigens and have immunosuppressive capabilities. Together with their relatively easy accessibility and expansion, they are an a...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327419/ https://www.ncbi.nlm.nih.gov/pubmed/35883121 http://dx.doi.org/10.1186/s13287-022-03028-2 |